Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
BioAtla
BCAB
$5.46M
| $2.06M | ﹤0.01% |
13,749
+4,577
| +50% | +$787K |
|
1977
TTEC Holdings
TTEC
$121M
| $2.06M | ﹤0.01% |
+60,922
| New | +$2.09M |
|
|
KRON
1978
DELISTED
Kronos Bio
KRON
| $2.06M | ﹤0.01% |
1,197,300
+272,400
| +29% | +$432K |
|
1979
iHeartMedia
IHRT
$543M
| $2.05M | ﹤0.01% |
564,327
+93,643
| +20% | +$311K |
|
1980
Universal Electronics
UEIC
$57.8M
| $2.05M | ﹤0.01% |
213,023
+34,354
| +19% | +$318K |
|
1981
Rayonier
RYN
$6.55B
| $2.05M | ﹤0.01% |
71,882
-199,124
| -73% | -$5.55M |
|
|
TGH
1982
DELISTED
Textainer Group Holdings limited
TGH
| $2.05M | ﹤0.01% |
52,000
+45,400
| +688% | +$1.66M |
|
1983
Cousins Properties
CUZ
$5.19B
| $2.04M | ﹤0.01% |
+89,631
| New | +$1.87M |
|
1984
DXP Enterprises
DXPE
$2.43B
| $2.04M | ﹤0.01% |
56,100
+45,500
| +429% | +$1.37M |
|
1985
Triple Flag Precious Metals
TFPM
$5.94B
| $2.04M | ﹤0.01% |
148,200
+128,300
| +645% | +$1.93M |
|
1986
Rigel Pharmaceuticals
RIGL
$681M
| $2.04M | ﹤0.01% |
158,113
-39,759
| -20% | -$538K |
|
1987
ARS Pharmaceuticals
SPRY
$509M
| $2.04M | ﹤0.01% |
304,300
-26,300
| -8% | -$176K |
|
1988
Aquestive Therapeutics
AQST
$463M
| $2.03M | ﹤0.01% |
1,230,196
+711,396
| +137% | +$1.29M |
|
1989
Trustmark
TRMK
$2.76B
| $2.03M | ﹤0.01% |
96,103
+67,523
| +236% | +$1.52M |
|
1990
iShares California Muni Bond ETF
CMF
$4.55B
| $2.03M | ﹤0.01% |
35,600
-108,800
| -75% | -$6.2M |
|
|
GIFI
1991
DELISTED
Gulf Island Fabrication
GIFI
| $2.03M | ﹤0.01% |
623,424
+16,800
| +3% | +$56.8K |
|
|
HA
1992
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.03M | ﹤0.01% |
188,100
-8,800
| -4% | -$76.2K |
|
1993
Avantis US Equity ETF
AVUS
$14B
| $2.02M | ﹤0.01% |
26,900
+19,500
| +264% | +$1.4M |
|
1994
AMREP Corp
AXR
$123M
| $2.02M | ﹤0.01% |
112,800
-7,000
| -6% | -$106K |
|
|
AEL
1995
DELISTED
American Equity Investment Life Holding Company
AEL
| $2.02M | ﹤0.01% |
+38,800
| New | +$1.56M |
|
1996
Bank of Marin Bancorp
BMRC
$472M
| $2.02M | ﹤0.01% |
114,168
+9,800
| +9% | +$178K |
|
1997
Otter Tail
OTTR
$3.71B
| $2.01M | ﹤0.01% |
25,504
-45,400
| -64% | -$3.41M |
|
1998
iShares Russell 3000 ETF
IWV
$19.6B
| $2.01M | ﹤0.01% |
+7,900
| New | +$1.9M |
|
1999
Hamilton Lane
HLNE
$4.91B
| $2M | ﹤0.01% |
25,031
-78,900
| -76% | -$5.67M |
|
2000
EverQuote
EVER
$892M
| $1.99M | ﹤0.01% |
306,628
+13,320
| +5% | +$112K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.